close
![]() |
![]() |
The agenda builder is a simple, light-weight tool to manage your schedule. There are filters to narrow your search by day, track and/or presenter.
| Time | Description | Room |
Expand all sessions
|
|||
|---|---|---|---|---|---|---|
| 08:35 AM |
Clinical Workshop - Session 3: HPV vaccines Chair(s): Xavier Bosch, Barcelona, Spain Margaret Stanley, Cambridge, United Kingdom |
517a |
Show details | |||
|
08:35 AM |
L |
Welcome & Opening Remarks
|
517a |
Add to my agenda | ||
|
08:45 AM |
L |
How do HPV vaccines protect?
|
517a |
Add to my agenda | ||
|
09:00 AM |
L |
HPV vaccines: Trials and results
|
517a |
Add to my agenda | ||
|
09:15 AM |
L |
Critical issues: Safety, Duration of protection,Cross-protection
|
517a |
Add to my agenda | ||
|
09:30 AM |
L |
Vaccination in infants, males, immune-compromised and mid-adult women
|
517a |
Add to my agenda | ||
|
09:45 AM |
L |
Questions & Answers
|
517a |
Add to my agenda | ||
|
10:00 AM |
L |
Coffee Break
|
517a |
Add to my agenda | ||
|
|
L |
-
|
517a |
Add to my agenda | ||
| 10:30 AM |
Clinical Workshop - Session 4: HIV and HPV Chair(s): Xavier Bosch, Barcelona, Spain |
517a |
Show details | |||
|
10:30 AM |
L |
HPV as risk factor for HIV
|
517a |
Add to my agenda | ||
|
10:45 AM |
L |
Burden of HPV disease in HIV infected individuals
|
517a |
Add to my agenda | ||
|
11:00 AM |
L |
Anal cancer: how and when to screen?
|
517a |
Add to my agenda | ||
|
11:15 AM |
L |
Questions & Answers
|
517a |
Add to my agenda | ||
| 11:30 AM |
Clinical Workshop - Lunch |
517a |
Add to my agenda | |||
| 12:45 PM |
Clinical Workshop - Session 5: Low Risk HPV Chair(s): Achim Schneider, Berlin, Germany Suzanne Garland, Parkville, Australia |
517a |
Show details | |||
|
12:45 PM |
L |
The burden of low risk HPV
|
517a |
Add to my agenda | ||
|
01:00 PM |
L |
External genital warts: diagnosis and treatment
|
517a |
Add to my agenda | ||
|
01:15 PM |
L |
Laryngeal papillomatosis
|
517a |
Add to my agenda | ||
| 01:30 PM |
Clinical Workshop - Session 6: Strategic thinking in cancer prevention Chair(s): Achim Schneider, Berlin, Germany Suzanne Garland, Parkville, Australia |
517a |
Show details | |||
|
01:30 PM |
L |
Cervical cancer prevention: using modeling to predict the optimal combinations of vaccination and screening
|
517a |
Add to my agenda | ||
|
01:45 PM |
L |
Monitoring HPV vaccination campaigns
|
517a |
Add to my agenda | ||
|
02:00 PM |
L |
Questions & Answers
|
517a |
Add to my agenda | ||
|
02:15 PM |
L |
Coffee Break
|
517a |
Add to my agenda | ||
|
02:45 PM |
L |
At the Junction of Biology and Behavior: Understanding and Promoting HPV Prevention
|
517a |
Add to my agenda | ||
|
03:00 PM |
L |
Public Health Education and Cervical Cancer prevention
|
517a |
Add to my agenda | ||
|
03:15 PM |
L |
WHO Effort to Control Cervical Cancer: from Infection to Palliative Care
|
517a |
Add to my agenda | ||
|
03:30 PM |
L |
World Effort to Bring HPV Vaccine to Developing Countries
|
517a |
Add to my agenda | ||
|
03:45 PM |
L |
Questions & Answers
|
517a |
Add to my agenda | ||
|
04:00 PM |
L |
Closing comments
|
517a |
Add to my agenda | ||
| 05:30 PM |
Opening Ceremonies - Keynote Presentation Chair(s): Marc Steben, Montreal, Canada |
517cd |
Show details | |||
|
05:30 PM |
L |
Keynote Presentation
|
517cd |
Add to my agenda | ||